These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24517042)

  • 1. New drugs to treat hereditary angioedema.
    Scheinfeld N
    Skinmed; 2013; 11(6):357-9. PubMed ID: 24517042
    [No Abstract]   [Full Text] [Related]  

  • 2. Three new drugs for hereditary angioedema.
    Med Lett Drugs Ther; 2010 Aug; 52(1345):66-7. PubMed ID: 20724964
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatment options for acute edema attacks caused by hereditary angioedema.
    Thomas MC; Shah S
    Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.
    Tilles SA; Borish L; Cohen JP
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):70-4. PubMed ID: 23352523
    [No Abstract]   [Full Text] [Related]  

  • 6. Replacement therapy with C1 esterase inhibitors for hereditary angioedema.
    Cicardi M; Zanichelli A
    Drugs Today (Barc); 2010 Nov; 46(11):867-74. PubMed ID: 21225025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful C1 esterase inhibitor therapy in a child with a novel type 3 hereditary angioedema-like syndrome.
    Rasmussen JL; Park MA; Fischer PR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):462-3. PubMed ID: 22626603
    [No Abstract]   [Full Text] [Related]  

  • 8. Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency.
    Bork K
    Expert Rev Clin Immunol; 2011 Nov; 7(6):723-33. PubMed ID: 22014012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful use of ecallantide to treat a hereditary angioedema attack after failure of C1 inhibitor prophylaxis.
    Burke S; Petrov A; Johnson J; MacGinnitie A
    Ann Allergy Asthma Immunol; 2011 Aug; 107(2):181-2. PubMed ID: 21802029
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 12. C1 inhibitor therapy and hereditary angioedema.
    Kalfus I; Frank M
    Am J Med; 2010 Apr; 123(4):e15; author reply e17. PubMed ID: 20362736
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency.
    Belbézier A; Boccon-Gibod I; Bouillet L
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2490-2491. PubMed ID: 33556593
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency.
    Suffritti C; Sartorio S; Berra S; Janu VP; Caccia S; Zanichelli A
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):963-965.e1. PubMed ID: 36379410
    [No Abstract]   [Full Text] [Related]  

  • 16. New Treatments for Hereditary Angioedema.
    Johnson NM; Phillips MA
    Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to response outcomes in hereditary angioedema.
    Pullman W
    Ann Allergy Asthma Immunol; 2011 Apr; 106(4):350; author reply 350-1. PubMed ID: 21457889
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical algorithm: Management of C1 inhibitor hereditary angioedema.
    Caballero T; Cabañas R; Pedrosa M
    Allergy; 2022 Mar; 77(3):1060-1063. PubMed ID: 34587298
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.
    Valerieva A; Staevska M; Jesenak M; Hrubiskova K; Sobotkova M; Zachova R; Hakl R; Andrejevic S; Suiter T; Grivcheva-Panovska V; Karadza-Lapic L; Soteres D; Shapiro R; Rumbyrt J; Tachdjian R; Mehta V; Hsu FI; Zanichelli A
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):799-802. PubMed ID: 31437566
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA approves new drug to prevent hereditary angioedema attacks.
    Lavine G
    Am J Health Syst Pharm; 2008 Nov; 65(22):2080. PubMed ID: 18997129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.